A clinical trial to look at how well cibisatamab works in combination with another drug called atezolizumab after pre-treatment with obinutuzumab to treat advanced colorectal cancer (CRC) after chemotherapy has not worked

A phase Ib, multicenter, open-label study to evaluate the safety, efficacy, and pharmacokinetics of cibisatamab in combination with atezolizumab after pretreatment with obinutuzumab in patients with previously treated metastatic, microsatellite-stable colorectal adenocarcinoma with high CEACAM5 expression